Amid the deepening implementation of the Healthy China 2030 strategy and the rapid convergence of a new global biotechnology revolution, in vitro diagnostics (IVD) has become more critical than ever. As a cornerstone of disease prevention, diagnosis, treatment, and health management, the pace of innovation and industrial upgrading in IVD carries profound implications for public health, economic development, and national competitiveness.
To systematically capture emerging opportunities and proactively address evolving challenges, the 13th China IVD Industry Development Conference will be held from 21-22 March, 2026, in Xiamen. The conference aims to create a high-level platform for strategic dialogue, exploring how deeper integration across the industrial chain, innovation chain, and value chain can accelerate China’s transition from a “follower” to a “co-runner,” and ultimately to a “leader” in the global IVD landscape—strengthening core competitiveness and expanding international influence.
The program is designed to tackle the industry’s most pressing and forward-looking topics. Discussions will examine the transformative impact of artificial intelligence on healthcare and industrial ecosystems, the opportunities and uncertainties arising from new healthcare policies such as test unbundling reforms, and the role of forward-looking standardization research in shaping future market order. Key sessions will also address the long-term implications of mutual recognition of laboratory test results, global expansion strategies for Chinese IVD companies, and the release of authoritative annual industry reports.
By covering policy, technology, market dynamics, regulation, and global strategy in a comprehensive agenda, the conference seeks to deliver cutting-edge insights and actionable perspectives. More importantly, it aims to break down traditional sector boundaries and foster deeper collaboration among stakeholders in medical devices, biotechnology, information technology, clinical medicine, and investment—driving coordinated innovation and sustainable growth across the entire IVD ecosystem.
TIME (UTC+8)
13:30–17:00 | 21 March 2026, Saturday
09:00–17:00 | 22 March 2026, Sunday
LOCATION
Hall 3, Xiamen International Expo Center
CONCURRENT EVENT HIGHLIGHTS
The 23rd China International In Vitro Diagnostic Expo by CACLP
The 11th China Experimental Medicine Conference and Series Sessions (Pathology, Molecular, Mass Spectrometry, Blood Transfusion, Laboratory Management, etc.)
The 1st China AI & Digital Twin Medicine Conference and Series Sessions
Enlightening Lab Med - The 9th IVD Youth Entrepreneur Forum
The 8th China IVD Distribution Enterprise Forum
The 6th China Key Raw Material & Parts Forum
The 2nd National Primary Healthcare Laboratory Forum
Go Global: China IVD International Forum 2026
… …
ORGANIZATION STRACTURE
· Honorary Chairman: Prof. Haibo SONG, Prof. Hualiang WANG, Prof. Jiatao LOU
· Chairman: Zhiming JIANG, Mingjian WU
· Executive Chairman: Jun WANG, Changqing LIN
Conference registration now available.
Copyright © 2026 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.